Suppr超能文献

肝脏海绵状血管瘤及硬化的血供来源与栓塞治疗

Source of blood supply and embolization treatment in cavernous hemangioma and sclerosis of the liver.

作者信息

Li G W, Zhao Z R, Li B S, Liu X G, Wang Z L, Liu Q F

机构信息

Gou-Wei Li, Bao-Sheng Li, Xiao-Gong Liu, Zhi-Liang Wang, Qing-Feng Liu, Department of General Surgery, Second Teaching Hospital Xi'an Medical University, Xi'an 710004, Shaanxi Province, China.

出版信息

World J Gastroenterol. 1997 Sep 15;3(3):147-9. doi: 10.3748/wjg.v3.i3.147.

Abstract

AIM

To investigate the source of the blood supply in carvenous hemangioma of liver (CHL), and provide a feasible treatment for CHL via thehepatic artery.

METHODS

(1) Portovenography, hepatic arteriography and portal vein staining were performed in 5 patients to determine the origin of the blood supply. Two casts of hepatic blood vessels from resected specimens were observed. (2) Clinical data from 75 patients (30 males, 45 females, aged 25-57 years, mean of 37.4) were obtained. Of these, 56 were of solitary type (44 on the right lobe, 12 on the left, with 4 having intraparenchyma), and 19 were of multiple type (9 on the right, 2 the left, 8 whole liver). Twenty-two patients were treated with sclerosis, 50 by embolization via hepatic artery, and 3 were excised.

RESULTS

In the 5 cases where portography was used, the contrast medium did not enter the tumor, and the tumor appeared as low density area, with the intrahepatic branches of the portal vein pushed aside. In the 5 cases with where portal vein staining was used, the normal liver parenchyma stained a deep blue; however, the tumor was not stained. The tumor area appeared as a round vacant cavity in the 2 specimen casts. For the 72 patients treated with sclerosis or embolization via hepatic artery or through interventional method, the tumors diminished by 10%-30% in diameter, and no tumors grew larger.

CONCLUSION

The blood supply of CHL originates from the hepatic artery. Tumors treated with sclerosis and embolization decreased in size or got fibrotic.

摘要

目的

探讨肝海绵状血管瘤(CHL)的血供来源,并通过肝动脉为CHL提供一种可行的治疗方法。

方法

(1)对5例患者进行门静脉造影、肝动脉造影和门静脉染色以确定血供来源。观察2个切除标本的肝血管铸型。(2)获取75例患者(男30例,女45例,年龄25 - 57岁,平均37.4岁)的临床资料。其中,56例为单发型(右叶44例,左叶12例,4例位于肝实质内),19例为多发型(右叶9例,左叶2例,全肝8例)。22例患者接受硬化治疗,50例通过肝动脉栓塞治疗,3例接受手术切除。

结果

在5例进行门静脉造影的患者中,造影剂未进入肿瘤,肿瘤表现为低密度区,门静脉肝内分支被推开。在5例进行门静脉染色的患者中,正常肝实质染成深蓝色;然而,肿瘤未染色。在2个标本铸型中,肿瘤区域呈现为圆形空洞。对于72例接受硬化治疗、肝动脉栓塞治疗或介入治疗的患者,肿瘤直径缩小了10% - 30%,且无肿瘤增大情况。

结论

CHL的血供来源于肝动脉。经硬化和栓塞治疗的肿瘤体积缩小或纤维化。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验